Post-Market Study of Low-flow ECCO2R Using PrismaLung+
Clinical trial NCT04617093 · COMPLETED
Trial details
- NCT number
- NCT04617093
- Sponsor
- Vantive Health LLC
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-30
- Primary completion
- 2023-12-05
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.